CenturyLink Investment Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-2,411
Closed -$235K 316
2015
Q1
$235K Buy
+2,411
New +$235K 0.08% 220